Longboard Pharmaceuticals Inc (NAS:LBPH)
$ 33.79 0.39 (1.17%) Market Cap: 1.31 Bil Enterprise Value: 999.79 Mil PE Ratio: 0 PB Ratio: 4.46 GF Score: 36/100

Longboard Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 18, 2023 / 08:30PM GMT
Release Date Price: $7.04 (+5.39%)
Ami Fadia
Needham & Company, LLC - Analyst

Good afternoon, everyone. Thank you for joining the next session with Longboard Pharmaceuticals. I'm Ami Fadia, one of the biotech analysts here at Needham. We're fortunate enough to have Brandi Roberts, CFO of the company, sharing with us an overview of the company. I just wanted to also remind our listeners that if you'd like me to ask any questions on your behalf, please send it over to me through the dashboard.

With that, Brandi, over to you, and we'll take some time at the end for Q&A.

Brandi Roberts
Longboard Pharmaceuticals, Inc. - EVP and CFO

Great. Thanks so much, Amy, and thanks to the Needham team for hosting today. Really appreciate it.

Before I get started, I do want to remind listeners that I will be making some forward-looking statements today. So for additional information, please check out our SEC filings that are available on our website as well as sec.gov.

I'd like to start off with our history. We have a pretty unique history as a company. We were founded by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot